Global X China Biotech ETF (HKG:2820)
76.88
+0.04 (0.05%)
Sep 23, 2026, 3:32 PM HKT
HKG:2820 Holdings Information
HKG:2820 is an equity ETF with a total of 46 individual holdings. The top holdings are Cash stock at 24.62%, WuXi Biologics at 11.10%, BeOne Medicines AG at 9.74%, Innovent Biologics at 9.07%, and WuXi AppTec at 8.76%.
Total Holdings
46
Top 10 Percentage
85.51%
Asset Class
Equity
ETF Category
Health Care
Assets
661.27M
PE Ratio
27.54
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | n/a | Cash | 24.62% |
| 2 | HKG: 2269 | WuXi Biologics (Cayman) Inc. | 11.10% |
| 3 | ONC | BeOne Medicines AG | 9.74% |
| 4 | HKG: 1801 | Innovent Biologics, Inc. | 9.07% |
| 5 | SHA: 603259 | WuXi AppTec Co., Ltd. | 8.76% |
| 6 | HKG: 9926 | Akeso, Inc. | 5.78% |
| 7 | HKG: 1177 | Sino Biopharmaceutical Limited | 4.46% |
| 8 | SHA: 600276 | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 4.39% |
| 9 | HKG: 1548 | Genscript Biotech Corporation | 3.85% |
| 10 | HKG: 3692 | Hansoh Pharmaceutical Group Company Limited | 3.75% |
| 11 | HKG: 1530 | 3SBio Inc. | 2.84% |
| 12 | HKG: 6990 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2.35% |
| 13 | HKG: 2228 | XtalPi Holdings Limited | 1.82% |
| 14 | SHA: 688266 | Suzhou Zelgen Biopharmaceuticals Co., Ltd. | 1.70% |
| 15 | SHE: 300759 | Pharmaron Beijing Co., Ltd. | 1.43% |
| 16 | HKG: 0867 | China Medical System Holdings Limited | 1.05% |
| 17 | SHA: 603087 | Gan & Lee Pharmaceuticals. | 0.89% |
| 18 | SHA: 688578 | Shanghai Allist Pharmaceuticals Co., Ltd. | 0.84% |
| 19 | SHE: 300347 | Hangzhou Tigermed Consulting Co., Ltd | 0.69% |
| 20 | SHE: 002252 | Shanghai RAAS Blood Products Co., Ltd. | 0.62% |
| 21 | SHA: 688331 | RemeGen Co., Ltd. | 0.48% |
| 22 | SHA: 688180 | Shanghai Junshi Biosciences Co., Ltd. | 0.47% |
| 23 | SHA: 688506 | Sichuan Biokin Pharmaceutical Co.,Ltd. | 0.41% |
| 24 | SHA: 600161 | Beijing Tiantan Biological Products Co., Ltd. | 0.39% |
| 25 | SHA: 600566 | Hubei Jumpcan Pharmaceutical Co., Ltd. | 0.38% |
As of Sep 21, 2026